Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice

Vaccine

Volumn 29, Issue 14, 2011, Pages 2568-2575

  Smith, Jennifer Humberd ^a   Brooks, Paula ^a   Johnson, Scott ^a   Tompkins, S Mark ^a   Custer, Koren M ^a   Haas, Debra L ^a   Mair, Raydel ^b   Papania, Mark ^b   Tripp, Ralph A ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Aerosol; Influenza; Vaccination

Indexed keywords

INFLUENZA VACCINE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; IMMUNE RESPONSE; INFLUENZA; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL;

ADMINISTRATION, INTRANASAL; AEROSOLS; ANIMALS; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; VACCINATION;

EID: 79952246359     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.059     Document Type: Article

References (45)

1. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Influenza-associated hospitalizations in the United States. JAMA 2004, 292(September (11)):1333-1340.
2. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289(January (2)):179-186.
3. Izurieta H.S., Thompson W.W., Kramarz P., Shay D.K., Davis R.L., DeStefano F., et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000, 342(January (4)):232-239.
4. Fox J.P., Cooney M.K., Hall C.E., Foy H.M. Influenza virus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol 1982, 116(August (2)):228-242.
5. Cabre M. Pneumonia in the elderly. Curr Opin Pulm Med 2009, 15(May (3)):223-229.
6. Tripp R.A., Tompkins S.M. Recombinant vaccines for influenza virus. Curr Opin Investig Drugs 2008, 9(August (8)):836-845.
7. Elliot A.J., Fleming D.M. Influenza and respiratory syncytial virus in the elderly. Expert Rev Vaccines 2008, 7(March (2)):249-258.
8. Fiore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009, 58(July (RR-8)):1-52.
9. The influence of Influenza: is the Influenza vaccine as useful as we thought?. Future Virol 2008, 3(5):419-421.
10. Fiore A.E., Shay D.K., Haber P., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007, 56(July (RR-6)):1-54.
11. Pruss-Ustun A.R., Hutin E.Y. Sharps injuries: global burden of disease from sharps injuries to health-care workers 2003, World Health Organization.
12. Le Brun P.P., de Boer A.H., Heijerman H.G., Frijlink H.W. A review of the technical aspects of drug nebulization. Pharm World Sci 2000, 22(June (3)):75-81.
13. Bennett W.D., Brown J.S., Zeman K.L., Hu S.C., Scheuch G., Sommerer K. Targeting delivery of aerosols to different lung regions. J Aerosol Med 2002, 15(Summer (2)):179-188.
14. Castro J.F., Bennett J.V., Rincon H.G., Munoz M.T., Sanchez L.A., Santos J.I. Evaluation of immunogenicity and side effects of triple viral vaccine (MMR) in adults, given by two routes: subcutaneous and respiratory (aerosol). Vaccine 2005, 23(January (8)):1079-1084.
15. Bennett J.V., Fernandez de Castro J., Valdespino-Gomez J.L., Garcia-Garcia Mde L., Islas-Romero R., Echaniz-Aviles G., et al. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren. Bull World Health Organ 2002, 80(10):806-812.
16. Sabin A.B., Flores Arechiga A., Fernandez de Castro J., Sever J.L., Madden D.L., Shekarchi I., et al. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines. JAMA 1983, 249(May (19)):2651-2662.
17. Dilraj A., Cutts F.T., de Castro J.F., Wheeler J.G., Brown D., Roth C., et al. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Lancet 2000, 355(March (9206)):798-803.
18. Dilraj A., Sukhoo R., Cutts F.T., Bennett J.V. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination. Vaccine 2007, 25(May (21)):4170-4174.
19. Wong-Chew R.M., Islas-Romero R., Garcia-Garcia Mde L., Beeler J.A., Audet S., Santos-Preciado J.I., et al. Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children. J Infect Dis 2004, 189(January (2)):254-257.
20. Cutts F.T., Clements C.J., Bennett J.V. Alternative routes of measles immunization: a review. Biologicals 1997, 25(September (3)):323-338.
21. Reed L.J., Meunch H. A simple method for estimating fifty percent endpoints. Am J Hyg 1938, 27:493-497.
22. Hinshaw V.S., Webster R.G., Easterday B.C., Bean W.J. Replication of avian influenza A viruses in mammals. Infect Immun 1981, 34(November (2)):354-361.
23. Ito R., Ozaki Y.A., Yoshikawa T., Hasegawa H., Sato Y., Suzuki Y., et al. Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia. Vaccine 2003, 21(June (19-20)):2362-2371.
24. Palmer D.F., Coleman M.T., Dowdle W.R., Schild G.C. Advanced laboratory techniques for influenza diagnosis. Immunology series 6 1975, U.S. Department of Health, Education, and Welfare, Washington, DC, pp. 51-52.
25. Chanock R.M., Murphy B.R., Collins P.L., Coelingh K.V., Olmsted R.A., Snyder M.H., et al. Live viral vaccines for respiratory and enteric tract diseases. Vaccine 1988, 6(April (2)):129-133.
26. Hobson D., Curry R.L., Beare A.S., Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972, 70(December (4)):767-777.
27. Tumpey T.M., Renshaw M., Clements J.D., Katz J.M. Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J Virol 2001, 75(June (11)):5141-5150.
28. Murphy B.R., Clements M.L. The systemic and mucosal immune response of humans to influenza A virus. Curr Top Microbiol Immunol 1989, 146:107-116.
29. Holmgren J., Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005, 11(April (4 Suppl.)):S45-S53.
30. Giudice E.L., Campbell J.D. Needle-free vaccine delivery. Adv Drug Deliv Rev 2006, 58(April (1)):68-89.
31. Low N., Kraemer S., Schneider M., Restrepo A.M. Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis. Vaccine 2008, 26(January (3)):383-398.
32. Cohen B.J., Parry R.P., Andrews N., Bennett A.M., Dennis J.H. Laboratory methods for assessing vaccine potency retained in aerosol outputs from nebulizers: application to World Health Organization measles aerosol project. Vaccine 2008, 26(June (27-28)):3534-3539.
33. Southam D.S., Dolovich M., O'Byrne P.M., Inman M.D. Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am J Physiol Lung Cell Mol Physiol 2002, 282(April (4)):L833-L839.
34. Jemski J.V., Walker J.S. Aerosol vaccination of mice with a live, temperature-sensitive recombinant influenza virus. Infect Immun 1976, 13(March (3)):818-824.
35. Asanuma H., Aizawa C., Kurata T., Tamura S. IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration. Vaccine 1998, 16(August (13)):1257-1262.
36. Price G.E., Soboleski M.R., Lo C.Y., Misplon J.A., Pappas C., Houser K.V., et al. Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses. Vaccine 2009, 27(November (47)):6512-6521.
37. Coutelier J.P., van der Logt J.T., Heessen F.W., Vink A., van Snick J. Virally induced modulation of murine IgG antibody subclasses. J Exp Med 1988, 168(December (6)):2373-2378.
38. Coutelier J.P., van der Logt J.T., Heessen F.W., Warnier G., Van Snick J. IgG2a restriction of murine antibodies elicited by viral infections. J Exp Med 1987, 165(January (1)):64-69.
39. Huber V.C., McKeon R.M., Brackin M.N., Miller L.A., Keating R., Brown S.A., et al. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Clin Vaccine Immunol 2006, 13(September (9)):981-990.
40. Huber V.C., Lynch J.M., Bucher D.J., Le J., Metzger D.W. Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections. J Immunol 2001, 166(June (12)):7381-7388.
41. Hovden A.O., Cox R.J., Haaheim L.R. Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice. Scand J Immunol 2005, 62(July (1)):36-44.
42. Barnard D.L. Animal models for the study of influenza pathogenesis and therapy. Antiviral Res 2009, 82(May (2)):A110-A122.
43. Maher J.A., DeStefano J. The ferret: an animal model to study influenza virus. Lab Anim (NY) 2004, 33(October (9)):50-53.
44. van Riel D., Munster V.J., de Wit E., Rimmelzwaan G.F., Fouchier R.A., Osterhaus A.D., et al. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 2007, 171(October (4)):1215-1223.
45. Plopper C.G., Hill L.H., Mariassy A.T. Ultrastructure of the nonciliated bronchiolar epithelial (Clara) cell of mammalian lung. III. A study of man with comparison of 15 mammalian species. Exp Lung Res 1980, 1(June (2)):171-180.